-
Je něco špatně v tomto záznamu ?
Characterizing crystal disorder of trospium chloride: a comprehensive,(13) C CP/MAS NMR, DSC, FTIR, and XRPD study
M. Urbanova, A. Sturcova, J. Brus, H. Benes, E. Skorepova, B. Kratochvil, J. Cejka, I. Sedenkova, L. Kobera, O. Policianova, A. Sturc,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
23359249
DOI
10.1002/jps.23457
Knihovny.cz E-zdroje
- MeSH
- benziláty chemie MeSH
- diferenciální skenovací kalorimetrie MeSH
- difrakce rentgenového záření MeSH
- krystalizace MeSH
- magnetická rezonanční spektroskopie MeSH
- nortropany chemie MeSH
- prášková difrakce MeSH
- spektroskopie infračervená s Fourierovou transformací MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Analysis of C cross-polarization magic angle spinning (CP/MAS) nuclear magnetic resonance (NMR), differential scanning calorimetry (DSC), Fourier transform infrared (FTIR), and X-ray powder diffraction data of trospium chloride (TCl) products crystallized from different mixtures of water-ethanol [φ(EtOH) = 0.5-1.0] at various temperatures (0°C, 20°C) and initial concentrations (saturated solution, 30%-50% excess of solvent) revealed extensive structural variability of TCl. Although (13) C CP/MAS NMR spectra indicated broad variety of structural phases arising from molecular disorder, temperature-modulated DSC identified presence of two distinct components in the products. FTIR spectra revealed alterations in the hydrogen bonding network (ionic hydrogen bond formation), whereas the X-ray diffraction reflected unchanged unit cell parameters. These results were explained by a two-component character of TCl products in which a dominant polymorphic form is accompanied by partly separated nanocrystalline domains of a secondary phase that does not provide clear Bragg reflections. These phases slightly differ in the degree of molecular disorder, in the quality of crystal lattice and hydrogen bonding network. It is also demonstrated that, for the quality control of such complex products, (13) C CP/MAS NMR spectroscopy combined with factor analysis (FA) can satisfactorily be used for categorizing the individual samples: FA of (13) C CP/MAS NMR spectra found clear relationships between the extent of molecular disorder and crystallization conditions. © 2013 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 102:1235-1248, 2013.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13031665
- 003
- CZ-PrNML
- 005
- 20131007125720.0
- 007
- ta
- 008
- 131002s2013 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/jps.23457 $2 doi
- 035 __
- $a (PubMed)23359249
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Urbanova, Martina $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, 162 06 Prague 6, Czech Republic.
- 245 10
- $a Characterizing crystal disorder of trospium chloride: a comprehensive,(13) C CP/MAS NMR, DSC, FTIR, and XRPD study / $c M. Urbanova, A. Sturcova, J. Brus, H. Benes, E. Skorepova, B. Kratochvil, J. Cejka, I. Sedenkova, L. Kobera, O. Policianova, A. Sturc,
- 520 9_
- $a Analysis of C cross-polarization magic angle spinning (CP/MAS) nuclear magnetic resonance (NMR), differential scanning calorimetry (DSC), Fourier transform infrared (FTIR), and X-ray powder diffraction data of trospium chloride (TCl) products crystallized from different mixtures of water-ethanol [φ(EtOH) = 0.5-1.0] at various temperatures (0°C, 20°C) and initial concentrations (saturated solution, 30%-50% excess of solvent) revealed extensive structural variability of TCl. Although (13) C CP/MAS NMR spectra indicated broad variety of structural phases arising from molecular disorder, temperature-modulated DSC identified presence of two distinct components in the products. FTIR spectra revealed alterations in the hydrogen bonding network (ionic hydrogen bond formation), whereas the X-ray diffraction reflected unchanged unit cell parameters. These results were explained by a two-component character of TCl products in which a dominant polymorphic form is accompanied by partly separated nanocrystalline domains of a secondary phase that does not provide clear Bragg reflections. These phases slightly differ in the degree of molecular disorder, in the quality of crystal lattice and hydrogen bonding network. It is also demonstrated that, for the quality control of such complex products, (13) C CP/MAS NMR spectroscopy combined with factor analysis (FA) can satisfactorily be used for categorizing the individual samples: FA of (13) C CP/MAS NMR spectra found clear relationships between the extent of molecular disorder and crystallization conditions. © 2013 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 102:1235-1248, 2013.
- 650 _2
- $a benziláty $x chemie $7 D001561
- 650 _2
- $a diferenciální skenovací kalorimetrie $7 D002152
- 650 _2
- $a krystalizace $7 D003460
- 650 _2
- $a magnetická rezonanční spektroskopie $7 D009682
- 650 _2
- $a nortropany $x chemie $7 D009662
- 650 _2
- $a prášková difrakce $7 D033362
- 650 _2
- $a spektroskopie infračervená s Fourierovou transformací $7 D017550
- 650 _2
- $a difrakce rentgenového záření $7 D014961
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Sturcova, Adriana $u -
- 700 1_
- $a Brus, Jiri $u -
- 700 1_
- $a Benes, Hynek $u -
- 700 1_
- $a Skorepova, Eliska $u -
- 700 1_
- $a Kratochvil, Bohumil $u -
- 700 1_
- $a Cejka, Jan $u -
- 700 1_
- $a Sedenkova, Ivana $u -
- 700 1_
- $a Kobera, Libor $u -
- 700 1_
- $a Policianova, Olivia $u -
- 700 1_
- $a Sturc, Antonin $u -
- 773 0_
- $w MED00002895 $t Journal of pharmaceutical sciences $x 1520-6017 $g Roč. 102, č. 4 (2013), s. 1235-48
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23359249 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20131002 $b ABA008
- 991 __
- $a 20131007130241 $b ABA008
- 999 __
- $a ok $b bmc $g 995752 $s 830110
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 102 $c 4 $d 1235-48 $i 1520-6017 $m Journal of pharmaceutical sciences $n J Pharm Sci $x MED00002895
- LZP __
- $a Pubmed-20131002